Annual report pursuant to Section 13 and 15(d)

Concentrations

v3.19.1
Concentrations
12 Months Ended
Dec. 31, 2018
Risks and Uncertainties [Abstract]  
Concentrations

Note 10 - Concentrations

 

Sales

 

During the year ended December 31, 2018, we had three significant customers which accounted for 20%, 12% and 11% of sales.

 

Supplier

 

We also have a single source for our bioelectric medical devices, which account for 100% of our sales. The interruption of products provided by this supplier would adversely affect our business and financial condition unless an alternative source of products could be found.

 

Accounts Receivable

 

At December 31, 2018, we had three customers which accounted for 42%, 30% and 28% of our accounts receivable balances.